wiseowl research - 7.6c buy recommendation, page-38

If a patient comes to me with asthma i will give him asthma action plan and lot more medicines and pt can monitor their symptoms without wheezometer thats big positive in asthma management
There are no recent develoments lately in asthma treatment but wheezometer story got picked up by many so share price moved up from cents to lot more
I believe the isn story and hold it initially then they did consolidation and i thought company had issues within major shareholders so i sold it early my biggest mistake for 2013
Now i was researching alt scenario lately
If a lady comes to me with stress incontinence secondary to any cause i hardly can offer any treatment except referral to urogynaecologist or some symptomatic treatment
I researched extensively into alt and bought around 2.3 and some yesterday around 2.6
In my opinion this is not life threatening in comparison to asthma but socially it has immense nasty consequences if company manage to does some publicity to few big surgeries we will all b very rewarded
Its non invasive treatment
It has less side effects
It can rock
I do believe the story and will try to hold this time
Cheers